N-(3-chloro-4-fluorophenyl)-7-methoxy -6-(3-morpholinopropoxy)quinazolin-4-amine (50 mg)
Product No.:
CNGT-95-0050
N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine
Product No.:CNGT-95
CAS No.:184475-35-2
|
|
Product Name: |
N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine |
Synonyms: |
4-(3-Chloro-4-fluorophenylamino)-7-methoxy-6-[3-(4-morpholinyl)propoxy]quinazoline;Gefitinib |
|
CAS No.: |
184475-35-2 |
Molecular Formula: |
|
Molecular Weight: |
|
Application: |
Reference standard for [11C]NGT |
Presentation: |
Packaged in amber vial or amber screw cap vials with teflon-coated stoppers under argon atmosphere. |
Note
- Care must be taken when handling this product.
- Do not contact skin or eyes.
- Do not ingest or inhale.
- Store at <-20℃. Protect from light.(Short-term storage (<1 month) at higher temperatures (e.g. during transport) does not affect product quality)
- It shall be only used by qualified personnel.
Order Number
- CNGT-95-0010x 10mg per vial
- CNGT-95-0020x 20mg per vial
- note: x includes A B C and D, A refers to 2ml vial; B refers to 4.5ml vial; C refers to 8ml vial; D refers to 30ml vial
- *Customized dispensing is available
Literature
- Manrner T.J. et al. Synthesis of 2’-deoxy-2’-[18F]fluoro-beta-D-arabinofuranosyl nucleosides, [18F]FAU, [18F]FMAU, [18F]FBAU, [18F]FIAU, as potential PET agents for imaging cellular proliferation. Nucl. Med. Biol. 2003, 30,215-224.
- Alauddin M.M. et al. Direct comparison of radiolabeled probes FMAU, FHBG, and FHPG as PET imaging agents for HSV1-tk expression in a human breast cancer model. Mol. Imaging 2004, 3, 76-84.
- Alauddin M.M. et al. Synthesis and evaluation of 2’-deoxy-2’-18F-fluoro-5-fluoro-1-beta-D-arabinofuranosyluracil as a potential PET imaging agent for suicide gene expression. J. Nucl. Med. 2004, 45, 2063-2069